乳腺癌相关淋巴水肿非药物干预的证据总结

目的 运用循证的方法 整合乳腺癌相关淋巴水肿非药物干预的最佳证据，为临床医护人员对淋巴水肿开展规范化评估和管理提供循证依据。方法 系统检索各指南网站及中英文数据库有关乳腺癌患者淋巴水肿预防和管理的相关指南、专家共识、系统评价等证据，检索时限为2016年1月—2022年1月。结果 共纳入25篇文献，包括6篇指南、4篇专家共识、15篇系统评价，围绕预防性干预、治疗性干预2个方面总结33条最佳证据。结论 该研究总结的证据可用于防治乳腺癌淋巴水肿，医护人员需结合文化背景、临床情境、患者意见，为淋巴水肿患者提供针对性的健康指导。

Evidence summary for non-pharmacological interventions of breast cancer-related lymphedema

Objective To integrate the best evidence of non-pharmacological interventions for breast cancer-related lymphedema with evidence-based methods，and to provide evidence-based bases for standardized evaluation and management of lymphedema for clinical medical staff. Methods The best evidence about the prevention and management of lymphedema in breast cancer patients were searched systematically，such as relevant guidelines，expert consensuses，systematic reviews and so on. The retrieval period was from January 2016 to January 2022. Results A total of 25 pieces of the literature were included，including 6 guidelines，4 expert consensuses and 15 systematic evaluations，and 33 pieces of best evidences were integrated from 2 aspects，namely the preventive intervention and therapeutic intervention. Conclusion The summarized evidence can be used for the prevention and treatment of breast cancer lymphedema，and medical staff should provide specific health guidance for patients with lymphedema based on cultural background，clinical situation，and patients’ opinions.